NCC Medical Team
|
Srinivas Bolisetty MBBS, MD, FRACP |
Dr Bolisetty is passionate about delivering the best personalised care to babies and families based on the best available contemporary evidence. He started his journey as a trainee in neonatal care at this hospital in 1994 and over the last 30 years, he cemented himself as a leader among the newborn specialists in achieving the consensus and reducing the variation in clinical practice within the Australasian region. He has several leading roles at national level including the Chair of the Australasian Neonatal Medicines Formulary Group (2013-current) (www.anmfonline.org) and the Chair of Neonatal Parenteral Nutrition Network (NPN) (2010-current). He was also Co-Chair of ANZNN Enteral Nutrition consensus group (2016-2022). He was the NICU Lead in NSW COVID Clinical Council assisting the Ministry of Health and clinicians during COVID pandemic. Dr. Bolisetty has also achieved seven accolades and awards since 2012 with the most recent award, “Highly commended for Outstanding Services to the Organisation” in SESLHD 2023 Annual awards. |
|
Prof Kei Lui MBBS (UNSW) MD FRACP |
Professor Kei Lui is the Clinical Academic and Senior Neonatologist (former medical co-director). Outside the Royal Hospital for Women, Local Health District and State Wide Forums, he has substantial management and leadership roles in the Australian and New Zealand Neonatal Network as the current chairman and on director board of the iNEO International Neonatal Network. Prof Lui is an UNSW faculty professor appointed in the School of Women’s and Children’s Health. His areas of research interest include neonatal outcomes, epidemiology and clinical trials. He has over 200 peer reviewed publications and a chief investigator in 8 recent or ongoing NHMRC/MRFF and 2 CIHR grants |
|
Ju Lee Oei FRACP, MD |
Professor Ju Lee Oei is a Senior Neonatologist and Conjoint Professor in Paediatrics at the School of Women’s and Children’s Health, University of NSW. She is also Honorary Associate Professor at the NHMRC Clinical Trials Centre, University of Sydney, and Research Associate at the Lambert Initiative for Cannabinoid Therapeutics, University of Sydney, and Research Associate at the Ingham Institute for Applied Research, Liverpool, Australia and Visiting Professor to the University of Malaya, Malaysia and the Northwest University, Shanxi Province, China. Since 2009, she continues as a Chair of the Perinatal Substance Use Special Interest Group of PSANZ. Her main research interests are in the use of oxygen in newborn resuscitation, perinatal substance use disorders and neonatal epidemiology. She has research collaborations with >20 countries, 76 publications in peer reviewed journals, a reviewer for 46 international journals and is an invited member of the Grant Review Panel of the National Health and Medical Research Council (NHMRC), Australia. |
|
Meredith Ward MBBS, FRACP |
Dr Meredith Ward is a Senior Neonatologist. Her clinical interests include supporting parental involvement in their child’s care, through the Family Integrated Care program, optimising neurodevelopmental aspects of neonatal intensive care for both term and preterm infants, optimising perioperative care of the sick neonate, and long term management of infants affected by maternal substance use during pregnancy. Dr Ward’s research interests include the study of endogenous neural stem cells as a potential therapy for newborn brain injury. |
|
Parag Mishra MBBS, MD, FRACP |
Dr. Parag Mishra is a Senior Neonatologist who has been working for more than 15 years at RHW. His area of neonatal interest includes neonatal ventilation and resuscitation, management of newborns with surgical problems and these are few of his comprehensive list of favourite topics. He is involved with recruitment and selection of neonatal trainees. He is a conjoint lecturer at UNSW and is involved with phase 3 medical student education. He actively participates in Junior Medical officer training and education. |
|
John Smyth MBChB, FRACP FRCPCH |
Dr. Smyth is a Senior Neonatologist. He worked in both paediatrics and neonatology in New Zealand and the United Kingdom for 17 years before joining the team in NCC. He has travelled around the world and his areas of interest include EEG monitoring, neonatal ventilation, palliative care, infection control and education. |
|
Tim Schindler BMedSc, MBBS, FRACP, CCPU, PhD |
Associate Professor Schindler is a Senior Staff Specialist Neonatologist. He developed a passion for neonatal medicine during his time completing paediatric training at Sydney Children's Hospital just next door. He has worked in the Royal Hospital for Women's Neonatal Intensive Care Unit for over 15 years at every level from junior resident to consultant neonatologist. His areas of interest include bedside ultrasound, teaching and neonatal research. |
|
Dr Silvia Goldstein MBBS, DCH, FRACP, MPH |
Dr. Silvia Goldstein is the Developmental Paediatrician of NCC. She has held this position since 2019 and is truly dedicated. She oversees the Growth and Development Clinic, which operates 2 days/week and sees more than 400 infants and children per year. The team consists of Silvia, a clinical psychologist and a physiotherapist. The clinic provides follow-up data for the state-wide Neonatal Intensive Care Unit Data Collection. Silvia uses the Bayley Scales of Infant and Toddler Development for developmental assessments. Her areas of interest include early diagnosis of neurodevelopmental conditions and improving long-term neurodevelopmental outcomes. |
|
Dr Sarah-Jane Tapawan MD, MRCPH |
Dr. Tapawan is a Career Medical Officer and Conjoint Associate Lecturer in the School of Women’s and Children’s Health, University of NSW. She joined Newborn Care team in 2018. She is involved in quarterly NCC Orientation and Induction for residents, mortality and morbidity meeting, infection control-related audits, quality improvement and policy development. Her areas of interest include postnatal CMV infection, neurodevelopment, infection control, and education. |
|
Dr Trish Parmar MB Bch BAO , MRCPCH |
Dr Parmar has been a neonatal fellow at the Royal Hospital for Women since 2021. Her areas of interests include neonatal nutrition, NAVA ventilation,neonatal resuscitation and education of junior medical staff. |
|
Dr Fatima Perez RN, MD |
Dr. Perez is a board-certified doctor in the Philippines before coming to Australia for fellowship training. She received her medical degree in Manila, Philippines in 2014 then her Paediatric residency at the St. Luke’s Medical Centre. In 2019, Fatima decided to pursue specialisation in neonatology and she joined The Royal Hospital for Women. She has broaden her experience and enhanced her skills in intensive care for infants and has developed a strong focus on health education and holistic care of newborns, parents and families. Her interests are focused on improving communication within the NICU, both between families and clinicians using quality improvement methods and frameworks. |
